Idiopathic Retroperitoneal Fibrosis clinical trials

Explore recruiting idiopathic retroperitoneal fibrosis clinical trials.

Recruiting idiopathic retroperitoneal fibrosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Idiopathic Retroperitoneal Fibrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

METRO Early discontinuation of steroid treatment in negative FDG-PET/CT patients with idiopathic retroperitoneal fibrosis. A prospective multicentric study

France

Therapeutic use (Phase IV) EU CTIS Study details

Idiopathic Retroperitoneal Fibrosis trials by city

Idiopathic Retroperitoneal Fibrosis in Toronto Idiopathic Retroperitoneal Fibrosis in Vancouver Idiopathic Retroperitoneal Fibrosis in Montreal Idiopathic Retroperitoneal Fibrosis in Calgary Idiopathic Retroperitoneal Fibrosis in Edmonton Idiopathic Retroperitoneal Fibrosis in Ottawa Idiopathic Retroperitoneal Fibrosis in Winnipeg Idiopathic Retroperitoneal Fibrosis in Quebec City Idiopathic Retroperitoneal Fibrosis in Hamilton Idiopathic Retroperitoneal Fibrosis in Kitchener Idiopathic Retroperitoneal Fibrosis in London Idiopathic Retroperitoneal Fibrosis in Halifax Idiopathic Retroperitoneal Fibrosis in New York Idiopathic Retroperitoneal Fibrosis in Los Angeles Idiopathic Retroperitoneal Fibrosis in Chicago Idiopathic Retroperitoneal Fibrosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease